Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-10-25

Clinical Trial Update: Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on ACT-IPT in schoolchildren in Kassena-Nankana, Ghana. The study assesses intermittent preventive treatment for malaria and pot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (ACT)

Snippet

Sponsor: Navrongo Health Research Centre, Ghana | Conditions: Malaria, Schistosomiasis | Phase 4 | Status: UNKNOWN